Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC FHD-609 | 2676211-64-4 | C47H56N8O6 | 25 MG
Supplier: Medchemexpress LLC 25MGHY153367
FHD-609 is a PROTAC degrader and inhibitor of BRD9 (Bromodomain-containing protein 9). It targets ncBAF and is intended for research related to various cancers that possess a mutation in a BAF complex subunit. This compound, when combined with Telomelysin or INO5401, may be instrumental in the treatment of adrenocortical carcinoma (ACC).
- PROTAC degrader and inhibitor of BRD9
- Targets ncBAF
- Used for research on cancers with BAF complex subunit mutations
- May play a role in adrenocortical carcinoma (ACC) treatment in combination with Telomelysin or INO5401
- Demonstrated sustained BRD9 degradation and anti-tumor activities in SYO-1 xenograft mouse models
- Involved in a Phase 1 clinical trial for advanced synovial sarcoma
- Purity is 98.95%
- Appears as a white to off-white solid
- Soluble in DMSO at 100 mg/mL
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?